This post originally appeared on Fast Data Science’s blog on LinkedIn.
Clinical trials, the backbone of medical science advancement, often grapple with high costs, complexity, and lengthy timelines. Fast Data Science presents Fast Clinical AI, a game-changing solution that harnesses the power of Natural Language Processing (NLP) and predictive modelling to tackle these challenges head-on.
Fast Clinical AI automates the extraction of critical information from trial protocols, significantly reducing manual efforts. This tool identifies risk factors and predicts costs and enrolment criteria, ensuring efficient trial planning and execution.
By identifying potential risks early in the trial process, Fast Clinical AI allows researchers to take proactive measures, minimising the chances of trial delays or failures. This proactive approach ensures that trials are faster and more reliable.
Fast Clinical AI helps predict and manage the costs associated with clinical trials, ensuring better resource allocation. Reducing manual efforts and streamlining processes significantly reduces the time required to bring new treatments to market.
Explore how Fast Clinical AI can revolutionise your clinical trials. Visit here for more details. Learn more about clinical trial cost modelling with NLP and AI here. Connect with us today to see how we can support your clinical trial efforts. Let’s innovate together!
#ClinicalTrials #AI #NLP #HealthcareInnovation #FastClinicalAI
A clinical trial protocol is a document which serves as the step-by-step playbook for running the trial. The clinical trial protocol guides the study researchers to run the clinical trial effectively within a stipulated period. The prime focus of the clinical trial protocol is to ensure patients’ safety and data security. [1, 2] As the clinical trial protocol is an essential document for the seamless execution of the clinical trial, reviewing (peer-reviewing) the protocol is essential to ensure the scientific validity/viability/quality of the protocol.
Guest post by Safeer Khan, Lecturer at Department of Pharmaceutical Sciences, Government College University, Lahore, Pakistan Introduction As we move toward 2025, clinical trial regulations are undergoing significant transformation. This shift is being fueled by technological advancements, changing healthcare needs, and an increasing emphasis on transparency and patient safety. In this post, we will explore the key clinical trial regulations shaping the clinical trial landscape, the challenges professionals face, and the strategies they must adopt to navigate this ever-evolving environment.
Thomas Wood has recently joined the Clinical Trial Files podcast with Karin Avila and Taymeyah Al-Toubah, discussing the inception of the Clinical Trial Risk Tool, what impact AI can make in clinical trials, and what Alan Turing would make of it all. This is an episode dedicated to Alan Turing’s 113th birthday on 23 June 2025. You can find the episode on Spotify Apple Podcasts Amazon Music Podcast Index Fountain Podcast Addict Podverse.